Skip to main content
VulnerabilityPublished Updated

CVE-2026-28716: Acronis Cyber Protect 17 · Incorrect Authorization

Affects Acronis Cyber Protect 17Source CVE Database V5

0
Compare

Not known to be exploited · CVSS 4.4 Medium : upgrade to 41186 when convenient.

Data as of 29 Oct 2026, 19:04 UTC

CVSS 3.0 base score
4.4Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.09% chance of exploitation in 30 days – higher than 0% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available – fixed in 41186
CVSS:3.0/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 5 Mar 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 29 Oct 2026.

What to do

Upgrade Acronis Cyber Protect 17 to 41186.

Affected software

ProductAffectedFixed in
AcronisAcronis Cyber Protect 17Affected
  • ≥ unspecified, < 41186
Fixed in
  • 41186

AI-suggested

If you cannot patch yet, restrict local access to systems running Acronis Cyber Protect 17 to trusted personnel only and enforce strict access controls and user privilege management. Implement robust monitoring and auditing of user activities on these systems to detect unauthorized access attempts or suspicious behavior. Consider isolating backup management systems from general user environments to reduce exposure. Review and harden authorization policies within the product configuration if possible. Employ network segmentation and endpoint protection to limit the potential for attackers to gain local access. Conduct regular security assessments and penetration testing focused on privilege escalation and authorization bypass scenarios. Finally, maintain comprehensive backups and recovery plans to mitigate potential data manipulation impacts.

Description

Information disclosure and manipulation due to improper authorization checks. The following products are affected: Acronis Cyber Protect 17 (Linux, Windows) before build 41186.

References

Community reviews

Loading reviews…